Ocular Therapeutix, Inc. ( OCUL) - Key Metrics
OCUL Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q1 | ? | ? | ? | ? |
| 2025Q4 | ? | ? | ? | ? |
| 2025Q3 | $0.08 | -$0.38 | -$0.28 | -$0.31 |
| 2025Q2 | $0.08 | -$0.39 | -$0.32 | -$0.33 |
| 2025Q1 | $0.06 | -$0.38 | -$0.26 | -$0.28 |
OCUL Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q1 | ? | ? |
| 2025Q4 | ? | ? |
| 2025Q3 | ? | -7.74 |
| 2025Q2 | ? | -5.90 |
| 2025Q1 | ? | -4.85 |
OCUL Free Cash Flow Yield and Dividend Yield
| Date | Free Cash Flow Yield | Dividend Yield |
|---|---|---|
| 2026Q1 | -3.72% | ? |
| 2025Q4 | -2.11% | ? |
| 2025Q3 | -2.64% | ? |
| 2025Q2 | -3.53% | ? |
| 2025Q1 | -3.75% | ? |
OCUL
Price: $8.99
52 week price:
Payout Ratio Range:
Earnings Per Share: -1.44 USD
Exchange: NGM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 567800
Ebitda: -14.6 millionMarket Capitalization: 1.8 billion